Boeing Stock Climbs on MAX Certification Progress and Production Ramp

Boeing (NYSE: BA) shares climbed 2.5% on Thursday, opening at $224.36, as the company's recovery narrative continued to gather momentum on two fronts simultaneously: CEO Kelly Ortberg told a Wall Street conference that certification of the long-delayed 737 MAX 7 and MAX 10 is approaching its final stages, while a broadening group of institutional investors quietly builds positions in the stock.

The move puts Boeing closer to its 52-week high of $254.35 and well above its $176.77 low — a range that captures the distance the company has traveled since Ortberg took over in July 2024 amid safety concerns and production dysfunction. The stock has a long way to go to reach where most analysts think it belongs. The consensus price target across 23 analysts tracked by MarketBeat sits at $259.80, implying roughly 16% upside from Thursday's open.

Whether Boeing can close that gap depends on a handful of certification and production milestones that have been delayed so many times that the market has largely stopped believing them until they actually happen. Ortberg's conference remarks suggest at least some of those milestones may finally be real.

The MAX 7 and MAX 10: Years Late, Potentially Months Away

The 737 MAX 7 was originally supposed to begin deliveries in 2019. The 737 MAX 10 was planned for 2020. Both have been caught in a regulatory approval process that stretched across safety reviews, production quality concerns, and the broader trust deficit that developed between Boeing and the Federal Aviation Administration following the MAX 8 crises earlier in the decade.

Ortberg said Wednesday that Boeing is "clearly getting to the final stages" with both aircraft. The company is already building the planes and preparing for delivery commencement in 2027, with the flight test program subsequently shifting focus to the 777X — itself delayed multiple times, with commercial deliveries of the 777-9 also targeted for 2027.

"We are building the airplanes and getting ready to start the deliveries next year," Ortberg said — language that is more operationally specific than the forward guidance Boeing has been willing to provide through most of the past two years.

The FAA's separate clearance for Boeing to raise 737 MAX monthly production from 42 to 47 units represents the most concrete near-term progress signal. Ortberg indicated the company plans to implement that ramp over the next couple of months, with a further increase to 52 monthly planned thereafter and an eventual target of 63 planes per month. That trajectory — from 42 to 63 — represents a 50% production expansion from current authorized levels, and every unit of that expansion flows directly into the commercial backlog that Boeing's airline customers have been waiting years to clear.

The certification and production ramp are connected in a way that matters for Boeing's financial recovery. MAX 7 and MAX 10 approvals unlock deliveries to customers who have been paying deposits on planes they haven't received — and delivery converts backlog to cash in a business where cash generation has been the central investor concern since 2019.

Q1 Earnings Showed the Turnaround Has Genuine Substance

The investment thesis on Boeing isn't purely forward-looking. Q1 2026 earnings delivered a notable beat that shifted how analysts are thinking about the recovery timeline.

Boeing reported earnings of -$0.20 per share — a loss, but one that beat the consensus estimate of -$0.68 by $0.48. Revenue came in at $22.22 billion, slightly above the $22.15 billion analyst expectation, and up 14% year-over-year. A year earlier, the company was posting -$0.49 EPS. The directional improvement is unmistakable: Boeing is losing less money, generating more revenue, and beating expectations by wider margins than analysts had penciled in.

Full-year EPS consensus sits at -$0.15 — still negative, but approaching breakeven in a way that suggests the company could move to profitability earlier than the market's prior assumptions embedded in the stock price. The PE ratio of 108.91 reflects a company where investors are paying primarily for recovery potential rather than current earnings power, which is normal for businesses in genuine operational turnarounds.

The debt load remains the most significant structural risk. Debt-to-equity of 7.42 is among the highest in the aerospace sector, a legacy of the cash burn through years of production problems, safety recalls, and COVID-driven demand destruction in commercial aviation. Deleveraging requires sustained cash generation — which, in turn, requires the production ramp and certification schedule Ortberg outlined to execute on time. Every delivery delay compounds the debt problem.

Institutional Investors Are Rebuilding Positions

The broader institutional picture around Boeing stock is quietly constructive. AlphaQuest LLC raised its Boeing holdings by 3,375.8% during Q4, purchasing an additional 6,988 shares to bring its position to 7,195 shares valued at approximately $1.56 million at quarter-end. Multiple smaller advisors — Measured Wealth Private Client Group, Ares Financial Consulting, Strategic Wealth Advisors, and Kohmann Bosshard Financial Services — all initiated new Boeing positions in Q3 or Q4. American National Bank & Trust increased its stake by 124.2%.

Taken individually, none of these moves is market-moving. Collectively, they reflect a pattern: smaller institutional money, which tends to be more valuation-sensitive and less willing to hold through prolonged uncertainty, is beginning to treat Boeing as a recovery story worth owning rather than a risk to avoid. 64.82% of Boeing's stock is currently owned by hedge funds and other institutional investors — a concentration level that reflects the large-cap nature of the name but also signals that institutional sentiment has not collapsed despite years of operational difficulty.

The analyst community is broadly aligned on the recovery thesis. Of 23 analysts with active ratings, two assign Strong Buy, fifteen give Buy, four rate it Hold, and only two have issued Sell ratings. JPMorgan raised its price target from $245 to $270 with an Overweight rating. UBS lifted to $285 with a Buy. Royal Bank of Canada moved to $275. The consensus target of $259.80 has been building higher through 2026 as the operational evidence has improved.

The Three Variables That Define Boeing's Path to $260

FAA certification timing for MAX 7 and MAX 10. Ortberg's "final stages" language is the most constructive public statement Boeing has made on this subject in years. But the FAA's approval process doesn't operate on Boeing's preferred timeline, and every prior date given for these certifications has slipped. A 2026 certification leading to 2027 deliveries would be transformative for the financial model. Another delay would test investor patience at current valuations.

Production ramp execution. Moving from 42 to 47 to 52 monthly on the 737 MAX requires supply chain performance, FAA oversight approval at each step, and workforce execution that Boeing has struggled to maintain consistently. The authorized increase to 47 is the immediate test — if the company hits that run rate cleanly over the next two months, confidence in the subsequent move to 52 increases considerably. If quality issues emerge, the ramp slows and the delivery timeline extends.

Cash generation trajectory. The debt-to-equity ratio of 7.42 hangs over the equity story like a structural constraint. Analysts can build price targets of $260 or $285, but reaching them requires Boeing to demonstrate that the revenue growth and production expansion are translating into cash flow rather than being absorbed by operational costs and interest payments. The Q1 beat was encouraging. Sustained improvement over multiple quarters is what converts the recovery thesis from a bet to a trend.

What the 777X Delay Pattern Tells You About Risk

It's worth naming the Boeing-specific risk that doesn't appear in analyst consensus targets: the company has a demonstrated history of certifications arriving later than management's public statements implied. The 777X has been pushed back several times already. The MAX 7 and MAX 10 were supposed to be in service by 2019 and 2020 respectively. Ortberg's "final stages" language from Wednesday is more specific than anything Boeing has said publicly in years — but it's still language, not an FAA approval letter.

The market has priced Boeing at a discount to peers partly because of this credibility gap. $224 with a consensus target of $259 represents a larger-than-usual spread between current price and analyst fair value, which reflects not just uncertainty about the recovery timeline but a genuine trust deficit that the company has to earn its way out of through execution rather than promises.

Ortberg, who came to the role in July 2024 as an outside fix-it executive rather than a Boeing lifer, has taken a notably more disciplined approach to public guidance than his predecessors. His acknowledgment Wednesday that certifications have taken longer than he wanted is the kind of candor that Boeing's communication culture has historically avoided — and it's the kind of statement that, paradoxically, makes the "final stages" language more credible rather than less.

The Bottom Line

Boeing stock at $224 is a recovery trade with genuine underlying improvement and a specific set of catalysts that could close the gap to the $259.80 consensus target through the rest of 2026. The Q1 earnings beat, the production ramp authorization, and Ortberg's certification timeline update all point in the same direction: a company that spent years in crisis is making measurable progress toward operational normality.

The risks are real and Boeing-specific. The debt load constrains financial flexibility. The certification track record creates legitimate doubt about whether "final stages" means what it sounds like. And the 777X delay pattern is a reminder that Boeing has, before, been in final stages for a long time.

What the stock is pricing at $224 is a company where the turnaround is real but not yet proven at scale — where each quarterly earnings report, each FAA authorization, and each delivery milestone either adds to or subtracts from the credibility that determines how much of the gap to $259 closes and when.

The institutional money building positions in Q3 and Q4 appears to have concluded the turnaround is real enough to own. The 16% gap between Thursday's open and consensus target is the market's estimate of how much verification remains before that conclusion is fully reflected in the price.